How Qvin's Q-Pad Could Transform Women’s Health Through Menstrual Blood Testing

Today, we are honored to host Dr. Sara Naseri, CEO and Co-Founder of Qvin, a pioneering figure in women’s health innovation. In this session, we will explore the groundbreaking Q-Pad technology, the first FDA-approved menstrual blood test. This transformative innovation empowers women to monitor their health markers at home while enabling the early diagnosis of conditions like fertility issues, perimenopause, endometriosis, thyroid health and cervical cancer. (Monday, Dec 16, 5 PM ET) Click here to join webinar on LinkedIn:>>>

With its potential in oncology and ability to detect HPV, the Q-Pad plays a critical role in global cervical cancer prevention efforts. Join us to uncover how this pioneering tool is revolutionizing diagnostics, advancing early detection, and reshaping women’s healthcare for a more accessible and inclusive future.

Some of the main topics in this interview include:

• Qvin has demonstrated that menstrual blood can be a valuable diagnostic tool. What biomarkers can the Q-Pad currently detect, and what potential conditions could it help diagnose in the future?
• How does the Q-Pad compare to traditional diagnostic methods in terms of accuracy, convenience, and its impact on user experience and overall quality of life?
• Receiving FDA clearance is a major milestone. How significant is this for Qvin and the future of menstrual blood testing? What doors does it open for broader applications of your technology?
• With its non-invasive and self-administered nature, do you see the Q-Pad setting a new standard for diagnostics? How might this shape the future of healthcare accessibility?
• Research indicates the potential of menstrual blood testing for HPV and cervical cancer screening. Could you elaborate on how the Q-Pad might contribute to global cervical cancer prevention efforts?
• Beyond cervical cancer, do you see the Q-Pad being used for early detection of other cancers? Are there specific oncology applications you are currently exploring or envision for the future?